Viewing Study NCT04586582



Ignite Creation Date: 2024-05-06 @ 3:18 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04586582
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2020-10-02

Brief Title: ST-Segment Resolution as a Marker for Myocardial Scar in ST-Segment Elevation Myocardial Infarction
Sponsor: Chongqing Medical University
Organization: Chongqing Medical University

Study Overview

Official Title: The First Affiliated Hospital of Chongqing Medical University
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Clinical studies found that poor ST-segment resolution STR in electrocardiogram ECG occurred in major adverse cardiovascular events MACE arrhythmia and heart failure was significantly higher In clinical work in patients have poor ST-segment decline the investigators found by CMR-LGE the corresponding myocardium become thinner and other signs of myocardial scar

The investigators aimed to establish whether poor ST-segment resolution in ECG as well as CMR-LGE could detect the presence of myocardial scar in early STEMI patients In order to provide convenient cheap and widely used test method for patients who cannot tolerate CMR-LGE

42 STEMI patients with single-branch coronary artery stenosis or occlusion were enrolled ST-segment elevations were measured on the baseline and 24 hours after PCI The study population was divided into two groups by late gadolinium enhanced cardiac magnetic resonance LGE- CMR with transmural myocardial scar 75 or non-transmural myocardial scar 75
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None